Biomedican inc: Producing medical-grade cannabis more efficiently

1

Medical-use, non-GMO cannabinoids for 70-90% less than current, wholesale prices

2

Costs less than $1/gram per cannabinoid using 90% less resources; 4 patents pending

3

70+ press mentions; Forbes, Bloomberg, Nasdaq, Reuters, Maxim, Rolling Stones

4

Partnered with Institute of Genetics Moscow, Demark Technical University, Imperial College UK

5

CBG reduces pain, inflammation; treats Glaucoma, Huntington's disease, IDB

6

THCV helps with diabetes, inflammation, neuroprotection, & bone growth

7

One of the fastest growing markets in the world; expected to reach $25B in 2025

We believe that biosynthesis will shape the future and significantly influence the production of food, supplements, medical drugs, and other valuable organic compounds. We have identified rare cannabinoids as the starting point due to the high demand and limited availability. However, this is just the beginning, and we

Biomedican inc

Producing medical-grade cannabis more efficiently

$220,467

Highlights

Our Team

Pitch